跳至主要内容
临床试验/ACTRN12616000403437
ACTRN12616000403437已完成未知

Safety study of sibling cord blood cell infusion to children with cerebral palsy

Murdoch Childrens Research Institute0 个研究点目标入组 12 人开始时间: 2016年3月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
1 Years 至 16 Years(—)
性别
All

入选标准

  • 1.Diagnosis of any type of CP
  • 2.CP of any severity
  • 3.A record of sibling CBU in storage at a TGA accredited private cord blood bank
  • 4.Ability to travel to one of the trial centres
  • 5.Ability to participate in assessments
  • 6.Informed consent by parents

排除标准

  • 1.presence of progressive neurological disease
  • 2.known genetic disorder
  • 3.known brain dysplasia
  • 4.immune system disorder or immune deficiency syndrome
  • 5.infectious disease markers showing up on the virology screen
  • 6.evidence of cord blood unit contamination, or fewer than 10^7 cells/kg body mass
  • 7.ventilator support
  • 8.ill health, or if the participant’s medical condition does not allow safe travel
  • 9.previous cell therapy
  • 10.Botulinum toxin A within 3 months before or after infusion
  • 11.Surgery within 3 months before or after infusion
  • 12.Cannot obtain parental consent

研究者

相似试验